Tibet Pharmaceutical Industry: Accumulated a total of 178 million yuan to repurchase 1.24% of shares.

Tibet Pharmaceuticals announced that the company initiated a share repurchase plan on December 18, 2025, with an expected repurchase amount of 170 million to 200 million yuan. The repurchased shares will be used for employee shareholding plans or equity incentives, with the implementation period ending on December 17, 2026. As of the end of January 2026, the company has repurchased a total of 4.001 million shares, accounting for 1.24% of the total share capital, and paid a total amount of 178 million yuan. The repurchase price range is 42.66 yuan per share to 45.98 yuan per share.